"Biliary tract cancer" trang 1 - tải miễn phí từ tailieunhanh
Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: A real-world experience

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: A real-world experience
12    90    0
Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
15    67    1
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multiinstitutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multiinstitutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
8    92    1
Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization – Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial

Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization – Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial
11    230    1
Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015

Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
12    2    1
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
8    66    1
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
10    81    1
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, noncomparative, randomized, multicenter phase II study

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, noncomparative, randomized, multicenter phase II study
7    94    0
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
9    53    2
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
8    50    1
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
12    64    1
The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: A retrospective study

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: A retrospective study
7    50    1
Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians

Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians
9    26    1
Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
7    1    1
Association between shift work and the risk of death from biliary tract cancer in Japanese men

Association between shift work and the risk of death from biliary tract cancer in Japanese men
6    64    1
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models

Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models
10    52    1
Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with advanced biliary tract cancer in China

Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with advanced biliary tract cancer in China
9    1    1
Chemotherapy and targeted therapy for advanced biliary tract cancers: An umbrella review

Chemotherapy and targeted therapy for advanced biliary tract cancers: An umbrella review
26    4    1
Ebook Cancer epidemiology and prevention (4/E): Part 2

Ebook Cancer epidemiology and prevention (4/E): Part 2
716    109    0
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
9    67    0